🇺🇸 Statins, HMG CoA in United States

34 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 34

Most-reported reactions

1. Hypertension — 6 reports (17.65%)
2. Myocardial Infarction — 5 reports (14.71%)
3. Blood Cholesterol Increased — 4 reports (11.76%)
4. Myalgia — 4 reports (11.76%)
5. Dizziness — 3 reports (8.82%)
6. Drug Ineffective — 3 reports (8.82%)
7. Pain — 3 reports (8.82%)
8. Abnormal Behaviour — 2 reports (5.88%)
9. Diabetes Mellitus — 2 reports (5.88%)
10. Fatigue — 2 reports (5.88%)

Source database →

Frequently asked questions

Is Statins, HMG CoA approved in United States?

Statins, HMG CoA does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Statins, HMG CoA in United States?

National Heart, Lung, and Blood Institute (NHLBI) is the originator. The local marketing authorisation holder may differ — check the official source linked above.